AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Smiling woman embraces another

4 huge Medicare pay reforms are part of new bipartisan House bill

| 5 Min Read
Eyeball with target

AMA takes fight to Wisconsin optometrists performing eye surgeries

| 5 Min Read
Baby with bandage on upper thigh

Measles is spreading. Vaccination remains our best defense.

| 4 Min Read
Figure stands with giant pencil and checklist

How to know it is time to apply for AMA Joy in Medicine recognition

| 7 Min Read